Immune Effects of Alarelin on Ovarian Development and GnRH Receptor Mrna Expression Levels of Pituitary in Tilapia (oreochromis Niloticus)

Huizan Yang,Guanghua Huang,Min Lv,Yong Lin,Rui Wang,Lan Zeng,Huawei Ma,Tingjun Hu
DOI: https://doi.org/10.4194/1303-2712-v19_4_03
2019-01-01
Turkish Journal of Fisheries and Aquatic Sciences
Abstract:The effects of a gonadotropin releasing hormone analogue (GnRH-a, alarelin) on ovarian development and the associated gene expression in the tilapia (Oreochromis niloticus) pituitary gland were investigated for 60 days. Eighty sexually mature female tilapia were randomly divided into group I (GI, 10 mu g alarelin), group II (GII, 15 mu g alarelin), group III (GIII, 20 mu g alarelin), and control group (GC). Anti-GnRH antibody levels peaked on day 30 in GI, days 40-50 in GII, and day 40 in GIII, and were highest in GII (P<0.05). The highest follicle stimulating hormone beta (FSH-beta) and luteinizing hormone beta (LH-beta) concentrations occurred in Gil and GIII on day 40, and were higher in GII than in the other groups (P<0.05). No significant differences in FSH-beta or LH-beta concentrations were observed between GI and CG. FSH-beta and GnRH receptor mRNA levels declined significantly in the pituitary after alarelin treatment, whereas LH-beta mRNA increased by day 60. Alarelin treatment promoted ovarian and follicular development, which has implications for novel GnRH-based techniques established to regulate sexual maturation in tilapia.
What problem does this paper attempt to address?